(Date:11/19/2009)...YORK, Nov. 19 NeoStem, I...s sent the following letter to its shareholders, d..., 2009, of China Biopharmaceuticals Holdings, Inc....based in the People,s Republic of China. The merge...ou Eyre Pharmaceutical Co. Ltd., CHBP,s primary op...
(Date:11/19/2009)...MALVERN, Pa. and WALTHAM, Mass., Nov. 19 /PRNewswi...ion Resources find that the leading driver of anti... is broad-spectrum activity against gram-positive ... organisms that can cause nosocomial pneumonia, su...rimarily for agents that provide appropriate cover...
(Date:11/19/2009)...REAL, Nov. 19 /PRNewswire/ - Aegera Therapeutics I...t in a randomized Phase 2B study of AEG35156, a ta...ent for multiple oncology indications. ,, The s...tudy of the X-Linked Inhibitor of Apoptosis (XIAP)...-dose Cytarabine and Idarubicin in AML Following F...
(Date:11/19/2009)... World,s Top Gene Synthesis Companies Fo...to Coordinate Best Practices in Risk Reduction ,...dwide Gene Synthesis Capacity , ...rld’s leading gene synthesis companies today... screening protocol to promote biosecurity in the ...
Breaking Biology Technology:NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 4..., Calif., Dec. 16 Neurobiological,Technologies, I...t Celtic,Pharmaceutical Holdings L.P. (Celtic) has...ld the worldwide rights and assets related to XERE...o receive milestone payments upon the,achievement ...s approved for,commercial sale, NTI is also entitl...
...Mass.Dec. 16 NxStage Medical, Inc. (Nasdaq: NXT... products, today announced that Jeffrey H. Burbank...Financial Officer, will be presenting at the JPMor..., 2009 at the Westin St. Francis Hotel in San Fran... scheduled for Wednesday, January 14th at 4:30 p.m...
... Forum Attendees to Keep up Fight, Restore U.S.,s ...lvania,s commitment to developing and diversifying...o weather the economic downturn and set the stage ...ward G. Rendell said today. , , "In Pennsylva...ovation economy, and we are working hard to take a...
Other Biology Technology:Neurobiological Technologies' Partner, Celtic Pharma, Provides Update on XERECEPT(R) Clinical Program and Planned Sale in 2009 2Neurobiological Technologies' Partner, Celtic Pharma, Provides Update on XERECEPT(R) Clinical Program and Planned Sale in 2009 3Neurobiological Technologies' Partner, Celtic Pharma, Provides Update on XERECEPT(R) Clinical Program and Planned Sale in 2009 4NxStage to Present at the JPMorgan Healthcare Conference 2Governor Rendell Says Life Science Industry Will Fuel New Breakthroughs, Generate Jobs for Decades to Come 2Governor Rendell Says Life Science Industry Will Fuel New Breakthroughs, Generate Jobs for Decades to Come 3...ValveBank system! Program your valve and TTL on-o..., 2000, XP using graphic 'click-and-drag' timebars...out program listings, then download your programs ..., EasyCode is used for programming before -- not...
T4 DNA Ligase from Invitrogen
Finnpipette BioControl Single Channel, 40-200ul from Thermo Scientific
Rabbit Anti-alpha-N-Catenin Polyclonal Antibody, Unconjugated from Cell Signaling Technology
Biology Products: